Your Current Location : Fund Card : Portfolio Classification |
|
|
|
Motilal Oswal S&P BSE Healthcare ETF |
[Equity: Index] |
|
|
|
|
Instruments Breakdown |
Instruments |
Composition |
Current Asset |
0.66 |
Equity |
99.34 |
|
|
Concentration Analysis |
Top 5 Holdings |
45.69% |
Top 10 Holdings |
62.03% |
Top 25 Holdings |
81.82% |
|
|
|
|
Sector Analysis |
Sector/Ratings |
Net Asset(%) |
Pharma & Biotech |
75.62 |
Healthcare |
23.72 |
Cash |
0.66 |
|
|
|
|
Portfolio Metrics |
|
PB Ratio |
5.14 |
PE Ratio |
39.86 |
|
|
Top 25 Holdings |
|
Holdings |
Net Asset(%) |
Sun Pharmaceutical Industries Limited |
17.56 |
Cipla Limited |
8.11 |
Dr Reddys Laboratories Limited |
7.52 |
Apollo Hospitals Enterprise Limited |
6.42 |
Max Healthcare Institute Limited |
6.08 |
DIVI LABORATORIES LTD |
4.40 |
Lupin Limited |
3.92 |
Aurobindo Pharma Limited |
3.08 |
Zydus Lifesciences Limited |
2.55 |
Torrent Pharmaceuticals Limited |
2.39 |
Fortis Health Care Ltd |
2.20 |
Alkem Laboratories Limited |
1.72 |
IPCA Laboratories Limited |
1.70 |
Laurus Labs Limited |
1.55 |
Abbott India Limited |
1.44 |
Glenmark Pharmaceuticals Limited |
1.44 |
Gland Pharma Limited |
1.28 |
Syngene International Limited |
1.25 |
Biocon Limited |
1.18 |
Global Health Limited |
1.18 |
J B Chemicals and Pharma Limited |
1.18 |
Krishna Inst of Medical Sciences Ltd. |
1.01 |
Ajanta Pharma Limited |
0.93 |
Narayana Hrudalaya Ltd |
0.87 |
Natco Pharma Limited |
0.86 |
|
|
|
|
|
|
Sector Analysis Graphical Mode |
|
|
|
|
|
|
|
|
|
|
|